EUVIMEDEUVIMED entdecken
Open Access

Association of Pancreas Volume With Adverse Clinical Outcomes

Philip Thomas, Celestin Missikpode, Omar Garcia Martinez iD, Ashish Verma iD, Runqi Zhao iD, Sophie E Claudel iD, Insa M Schmidt iD, Daniel H van Raalte iD, Petter Bjornstad, Brian T Layden, James P Lash iD, Sushrut S Waikar iD und 1 weitere

Journal of the American Heart Association · 2025

DOI: 10.1161/jaha.125.042348 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Heart Association, 2025. Verfasst von Philip Thomas und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Department of Medicine University of Illinois Chicago Chicago IL USA. Hauptthemen laut MEDLINE: Pancreas, Renal Insufficiency, Chronic, Cardiovascular Diseases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NIAID NIH HHS, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Chronic diseases may injure the pancreas and result in a reduction in pancreas volume (PV), which may adversely impact its critical role in endocrine and exocrine function. Less is known about whether individuals with smaller PV face higher risks of adverse clinical outcomes.

Methods

We estimated baseline age‐adjusted predicted PV (pPV) from abdominal magnetic resonance imaging in 36 592 UK Biobank participants. Since the initial magnetic resonance imaging occurred 9.0 (interquartile range, 7.5–10.1) years after baseline, we fit a linear regression equation that included age for the outcome of PV slope in 451 participants with repeat magnetic resonance imaging 2.8 (interquartile range, 2.2–4.8) years after the initial scan. Using these data, we calculated baseline age‐adjusted pPV slope by adding or subtracting the annual change to the initial PV measurement assuming linear change in PV over time. Multivariable‐adjusted proportional hazards models tested associations of pPV with incident chronic kidney disease, cardiovascular disease (CVD; myocardial infarction, heart failure, or stroke), and death.

Results

Participants (52.2% women) were 55±8 years old and had a pPV of 63.3±15.3 mL. During median follow‐up of 13.9 years, there were 757 incident chronic kidney disease, 1392 CVD, and 702 death events. In final adjusted models, participants in the first pPV quartile had a 1.67‐fold (95% CI, 1.34–2.07) and 1.28‐fold (95% CI, 1.10–1.49) increased risk of incident CVD and death compared with the fourth quartile, respectively. pPV had nonlinear associations with incident CVD and death (each P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PancreasRenal Insufficiency, ChronicCardiovascular DiseasesHumansFemaleMaleMiddle AgedMagnetic Resonance ImagingAgedOrgan SizeUnited KingdomRisk FactorsRisk AssessmentIncidenceTime FactorsAdultPrognosis

Stichwörter der Autor:innen

cardiovascular diseasedeathmagnetic resonance imagingpancreas volume

Autor:innen und Institutionen

  • Division of Nephrology, Department of Medicine University of Illinois Chicago Chicago IL USA.
  • Section of Nephrology, Department of Medicine Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center Boston MA USA.
  • Diabetes Center, Department of Internal Medicine Amsterdam University Medical Center Amsterdam The Netherlands.
  • Division of Metabolism, Endocrinology and Nutrition, Department of Medicine University of Washington Seattle WA USA.
  • Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine University of Illinois Chicago Chicago IL USA.

ORCID-Profile: Omar Garcia Martinez, Ashish Verma, Runqi Zhao, Sophie E Claudel, Insa M Schmidt, Daniel H van Raalte, James P Lash, Sushrut S Waikar, Anand Srivastava

Förderung

  • NIDDK NIH HHS
  • NIAID NIH HHS
  • NHLBI NIH HHS

Zitieren

APA

Thomas, P., Missikpode, C., Martinez, O. G., Verma, A., Zhao, R., Claudel, S. E., Schmidt, I. M., van Raalte, D. H., Bjornstad, P., Layden, B. T., Lash, J. P., Waikar, S. S., & Srivastava, A. (2025). Association of Pancreas Volume With Adverse Clinical Outcomes. Journal of the American Heart Association. https://doi.org/10.1161/jaha.125.042348

Vancouver

Thomas P, Missikpode C, Martinez OG, Verma A, Zhao R, Claudel SE, et al. Association of Pancreas Volume With Adverse Clinical Outcomes. Journal of the American Heart Association. 2025. doi:10.1161/jaha.125.042348

BibTeX
@article{Thomas2025,
  author = {Thomas, Philip and Missikpode, Celestin and Martinez, Omar Garcia and Verma, Ashish and Zhao, Runqi and Claudel, Sophie E and Schmidt, Insa M and van Raalte, Daniel H and Bjornstad, Petter and Layden, Brian T and Lash, James P and Waikar, Sushrut S and Srivastava, Anand},
  title = {Association of Pancreas Volume With Adverse Clinical Outcomes},
  journal = {Journal of the American Heart Association},
  year = {2025},
  doi = {10.1161/jaha.125.042348}
}
Kostenlos starten →